Nine (19.6%) of the cirrhotic population had positive COVID-19 IgM, IgG positivity was present in 15 (32.6%) of the cirrhotic population and dual antibody positivity was seen in 9 (19.6%) individuals with liver cirrhosis. Here, CD40LG is linked to COVID-19.